Mind Medicine (MindMed) Inc. Common Shares
MNMD
MNMD: Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
moreShow MNMD Financials
Recent trades of MNMD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MNMD's directors and management
Government lobbying spending instances
-
$30,000 Jul 19, 2023 Issue: Health Issues
New patents grants
-
Patent Title: 18-mc for treatment of substance use disorders Mar. 07, 2023
-
Patent Title: System and method for patient monitoring of gastrointestinal function using automated stool classifications Dec. 20, 2022
Federal grants, loans, and purchases
Followers on MNMD's company Twitter account
Number of mentions of MNMD in WallStreetBets Daily Discussion
Recent insights relating to MNMD
Recent picks made for MNMD stock on CNBC
ETFs with the largest estimated holdings in MNMD
Flights by private jets registered to MNMD